Systemic administration of erythropoietin inhibits retinopathy in RCS rats

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Shen, Weiyong ^a   Chung, Sook H ^a   Irhimeh, Mohammad R ^a   Li, Shiying ^a,b   Lee, So Ra ^a   Gillies, Mark C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; NERVE GROWTH FACTOR RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; APOPTOSIS; CYTOLOGY; DIABETIC RETINOPATHY; DRUG EFFECTS; FLOW CYTOMETRY; FLUORESCENCE ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; GLIA; IMAGE PROCESSING; METABOLISM; MUTANT RAT STRAIN; RAT; RETINA; RETINA BLOOD VESSEL; TUNEL ASSAY; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FLOW CYTOMETRY; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT ANTIBODY TECHNIQUE; IMAGE PROCESSING, COMPUTER-ASSISTED; IN SITU NICK-END LABELING; NEUROGLIA; RATS; RATS, MUTANT STRAINS; RECEPTOR, NERVE GROWTH FACTOR; RETINA; RETINAL VESSELS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84905972996     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104759     Document Type: Article

References (72)

1. Athanasiou D, Aguila M, Bevilacqua D, Novoselov SS, Parfitt DA, et al. (2013) The cell stress machinery and retinal degeneration. FEBS Lett 587: 2008-2017.
2. Barber AJ, Gardner TW, Abcouwer SF (2011) The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy. Invest Ophthalmol Vis Sci 52: 1156-1163.
3. Fleck BW (2013) Management of retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 98: F454-456.
4. Gardner TW, Antonetti DA, Barber AJ, LaNoue KF, Levison SW (2002) Diabetic retinopathy: more than meets the eye. Surv Ophthalmol 47 Suppl 2: S253-262. (Pubitemid 36351245)
5. Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, et al. (2013) Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology 120: 1254-1261.
6. Murakami T, Nishijima K, Akagi T, Uji A, Horii T, et al. (2012) Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Invest Ophthalmol Vis Sci 53: 1506-1511.
7. Rattner A, Sun H, Nathans J (1999) Molecular genetics of human retinal disease. Annu Rev Genet 33: 89-131. (Pubitemid 30083120)
8. Pennesi ME, Nishikawa S, Matthes MT, Yasumura D, LaVail MM (2008) The relationship of photoreceptor degeneration to retinal vascular development and loss in mutant rhodopsin transgenic and RCS rats. Exp Eye Res 87: 561-570.
9. Bharadwaj AS, Appukuttan B, Wilmarth PA, Pan Y, Stempel AJ, et al. (2013) Role of the retinal vascular endothelial cell in ocular disease. Prog Retin Eye Res 32: 102-180.
10. LaVail MM (2001) Legacy of the RCS rat: impact of a seminal study on retinal cell biology and retinal degenerative diseases. Prog Brain Res 131: 617-627.
11. Vollrath D, Feng W, Duncan JL, Yasumura D, D'Cruz PM, et al. (2001) Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci U S A 98: 12584-12589. (Pubitemid 33019989)
12. Shen WY, Lai CM, Lai YK, Zhang D, Zaknich T, et al. (2003) Practical considerations of recombinant adeno-associated virus-mediated gene transfer for treatment of retinal degenerations. J Gene Med 5: 576-587. (Pubitemid 40310401)
13. Prokosch V, Fink J, Heiduschka P, Melkonyan H, Thanos S (2011) VEGF, Ang-2 and SRIF associated abnormal postnatal development of the retinal capillary network in the Royal College of Surgeons rat. Exp Eye Res 92: 128-137.
14. Zambarakji HJ, Keegan DJ, Holmes TM, Halfyard AS, Villegas-Perez MP, et al. (2006) High resolution imaging of fluorescein patterns in RCS rat retinae and their direct correlation with histology. Exp Eye Res 82: 164-171. (Pubitemid 43063407)
15. Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, et al. (2003) Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization. Blood 102: 1340-1346. (Pubitemid 36988041)
16. Li F, Chong ZZ, Maiese K (2004) Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways. Neurosignals 13: 265-289. (Pubitemid 40073625)
17. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, et al. (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98: 1405-1413. (Pubitemid 43948065)
18. Mowat FM, Gonzalez F, Luhmann UF, Lange CA, Duran Y, et al. (2012) Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy. Am J Pathol 180: 1726-1739.
19. Barthelmes D, Irhimeh MR, Gillies MC, Karimipour M, Zhou M, et al. (2013) Diabetes impairs mobilization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Blood Cells Mol Dis 51: 163-173.
20. Chen J, Connor KM, Aderman CM, Smith LE (2008) Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118: 526-533. (Pubitemid 351206543)
21. Sullivan T, Rex TS (2011) Systemic gene delivery protects the photoreceptors in the retinal degeneration slow mouse. Neurochem Res 36: 613-618.
22. Rex TS, Wong Y, Kodali K, Merry S (2009) Neuroprotection of photoreceptors by direct delivery of erythropoietin to the retina of the retinal degeneration slow mouse. Exp Eye Res 89: 735-740.
23. Mitsuhashi J, Morikawa S, Shimizu K, Ezaki T, Yasuda Y, et al. (2013) Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats. Exp Eye Res 106: 64-73.
24. Shen W, Li S, Chung SH, Gillies MC (2010) Retinal vascular changes after glial disruption in rats. J Neurosci Res 88: 1485-1499.
25. Banin E, Dorrell MI, Aguilar E, Ritter MR, Aderman CM, et al. (2006) T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci 47: 2125-2134. (Pubitemid 46768297)
26. Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, et al. (2012) Conditional Mullercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32: 15715-15727.
27. Shen WY, Lai CM, Graham CE, Binz N, Lai YK, et al. (2006) Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia 49: 1690-1701. (Pubitemid 43848108)
28. Shen W, Lee SR, Araujo J, Chung SH, Zhu L, et al. (2014) Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Muller cell ablation. Glia 62: 1110-1124.
29. Shen W, Zhu L, Lee SR, Chung SH, Gillies MC (2013) Involvement of NT3 and P75(NTR) in photoreceptor degeneration following selective Muller cell ablation. J Neuroinflammation 10: 137.
30. Barthelmes D, Irhimeh MR, Gillies MC, Zhu L, Shen W (2013) Isolation and characterization of mouse bone marrow-derived Lin(-)/VEGF-R2(+) progenitor cells. Ann Hematol 92: 1461-1472.
31. Coorey NJ, Shen W, Chung SH, Zhu L, Gillies MC (2012) The role of glia in retinal vascular disease. Clin Exp Optom 95: 266-281.
32. Harada T, Harada C, Nakayama N, Okuyama S, Yoshida K, et al. (2000) Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 26: 533-541.
33. Ibanez CF, Simi A (2012) p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends in neurosciences 35: 431-440.
34. Wang M, Ma W, Zhao L, Fariss RN, Wong WT (2011) Adaptive Muller cell responses to microglial activation mediate neuroprotection and coordinate inflammation in the retina. J Neuroinflammation 8: 173.
35. Otani A, Dorrell MI, Kinder K, Moreno SK, Nusinowitz S, et al. (2004) Rescue of retinal degeneration by intravitreally injected adult bone marrow-derived lineage-negative hematopoietic stem cells. J Clin Invest 114: 765-774. (Pubitemid 39578735)
36. Yu DY, Cringle SJ (2001) Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 20: 175-208.
37. Braun RD, Linsenmeier RA, Goldstick TK (1995) Oxygen consumption in the inner and outer retina of the cat. Invest Ophthalmol Vis Sci 36: 542-554.
38. Yu DY, Cringle SJ (2005) Retinal degeneration and local oxygen metabolism. Exp Eye Res 80: 745-751.
39. Yu DY, Cringle SJ, Su EN, Yu PK (2000) Intraretinal oxygen levels before and after photoreceptor loss in the RCS rat. Invest Ophthalmol Vis Sci 41: 3999-4006.
40. Reichenbach A, Bringmann A (2013) New functions of Muller cells. Glia 61: 651-678.
41. Bringmann A, Iandiev I, Pannicke T, Wurm A, Hollborn M, et al. (2009) Cellular signaling and factors involved in Muller cell gliosis: neuroprotective and detrimental effects. Prog Retin Eye Res 28: 423-451.
42. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, et al. (2006) Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25: 397-424. (Pubitemid 44038611)
43. Dyer MA, Cepko CL (2000) Control of Muller glial cell proliferation and activation following retinal injury. Nat Neurosci 3: 873-880.
44. Besler C, Doerries C, Giannotti G, Luscher TF, Landmesser U (2008) Pharmacological approaches to improve endothelial repair mechanisms. Expert Rev Cardiovasc Ther 6: 1071-1082.
45. Urao N, Okigaki M, Yamada H, Aadachi Y, Matsuno K, et al. (2006) Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98: 1405-1413. (Pubitemid 43948065)
46. Chateauvieux S, Grigorakaki C, Morceau F, Dicato M, Diederich M (2011) Erythropoietin, erythropoiesis and beyond. Biochem Pharmacol 82: 1291-1303.
47. Merchionne F, Dammacco F (2009) Biological functions and therapeutic use of erythropoiesis-stimulating agents: perplexities and perspectives. Br J Haematol 146: 127-141.
48. Lifshitz L, Prutchi-Sagiv S, Avneon M, Gassmann M, Mittelman M, et al. (2009) Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Mol Immunol 46: 713-721.
49. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, et al. (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc Natl Acad Sci U S A 98: 4044-4049. (Pubitemid 32249895)
50. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, et al. (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97: 10526-10531.
51. Lipsic E, Westenbrink BD, van der Meer P, van der Harst P, Voors AA, et al. (2008) Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit. Eur J Heart Fail 10: 22-29.
52. Wang Q, Gorbey S, Pfister F, Hoger S, Dorn-Beineke A, et al. (2011) Long-term treatment with suberythropoietic Epo is vaso- and neuroprotective in experimental diabetic retinopathy. Cell Physiol Biochem 27: 769-782.
53. Slusarski JD, McPherson RJ, Wallace GN, Juul SE (2009) High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatr Res 66: 625-630.
54. McVicar CM, Hamilton R, Colhoun LM, Gardiner TA, Brines M, et al. (2011) Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 60: 2995-3005.
55. Otani A, Kinder K, Ewalt K, Otero FJ, Schimmel P, et al. (2002) Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat Med 8: 1004-1010. (Pubitemid 35033705)
56. Dorrell MI, Aguilar E, Jacobson R, Trauger SA, Friedlander J, et al. (2010) Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia 58: 43-54.
57. Mobius-Winkler S, Hollriegel R, Schuler G, Adams V (2009) Endothelial progenitor cells: implications for cardiovascular disease. Cytometry A 75: 25-37.
58. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat Med 9: 702-712. (Pubitemid 36749219)
59. Umemura T, Higashi Y (2008) Endothelial progenitor cells: therapeutic target for cardiovascular diseases. J Pharmacol Sci 108: 1-6.
60. Marzo F, Lavorgna A, Coluzzi G, Santucci E, Tarantino F, et al. (2008) Erythropoietin in heart and vessels: focus on transcription and signalling pathways. J Thromb Thrombolysis 26: 183-187.
61. Peterson TE, Katusic ZS (2007) EPO tecting the endothelium. Br J Pharmacol 150: 823-825. (Pubitemid 46536626)
62. Sanchis-Gomar F, Garcia-Gimenez JL, Pareja-Galeano H, Romagnoli M, Perez-Quilis C, et al. (2014) Erythropoietin and the heart: Physiological effects and the therapeutic perspective. Int J Cardiol 171: 116-125.
63. Ladeby R, Wirenfeldt M, Dalmau I, Gregersen R, Garcia-Ovejero D, et al. (2005) Proliferating resident microglia express the stem cell antigen CD34 in response to acute neural injury. Glia 50: 121-131. (Pubitemid 40695266)
64. Asheuer M, Pflumio F, Benhamida S, Dubart-Kupperschmitt A, Fouquet F, et al. (2004) Human CD34 + cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci U S A 101: 3557-3562. (Pubitemid 38338234)
65. Ritter MR, Banin E, Moreno SK, Aguilar E, Dorrell MI, et al. (2006) Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy. J Clin Invest 116: 3266-3276. (Pubitemid 44878641)
66. Jonas RA, Yuan TF, Liang YX, Jonas JB, Tay DK, et al. (2012) The spider effect: morphological and orienting classification of microglia in response to stimuli in vivo. PLoS One 7: e30763.
67. Stahl A, Buchwald A, Martin G, Junker B, Chen J, et al. (2010) Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina 30: 1524-1529.
68. Chen J, Connor KM, Aderman CM, Willett KL, Aspegren OP, et al. (2009) Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Invest Ophthalmol Vis Sci 50: 1329-1335.
69. Chen J, Smith LE (2008) A double-edged sword: erythropoietin eyed in retinopathy of prematurity. J Aapos 12: 221-222.
70. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M (2012) Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122: 4213-4217.
71. Chang ZY, Yeh MK, Chiang CH, Chen YH, Lu DW (2013) Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-alpha-induced damage. PLoS One 8: e55291.
72. Shen J, Wu Y, Xu JY, Zhang J, Sinclair SH, et al. (2010) ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD. Invest Ophthalmol Vis Sci 51: 35-46.